Please provide your email address to receive an email when new articles are posted on . A 24-year-old Guyanese man presented with a 3-month history of personality changes, abulia, headaches, nausea ...

On track to define optimal dosing interval and advance manufacturing scale up of REYOBIQ for pivotal trial readiness in late ...

When I found out I had a metastasis to my brain, I felt so uncertain, until I learned more about leptomeningeal disease. When I started having severe headaches back in November 2023 that were not my ...

New York, USA, Sept. 09, 2025 (GLOBE NEWSWIRE) -- Leptomeningeal Metastases Market to Exhibit Growth at a Paltry CAGR of 1.9% During the Forecast Period (2025–2034) | DelveInsight The leptomeningeal ...

A team of researchers has been able to add an important resource to study leptomeningeal disease by successfully growing and culturing circulating tumor cells derived from the cerebrospinal fluid of ...

The following represents disclosure information provided by authors of this manuscript. All relationships are considered compensated. Relationships are self-held unless noted. I = Immediate Family ...

Please provide your email address to receive an email when new articles are posted on . Treatment appeared well tolerated at the highest dose level of 50 mg. Researchers observed only mild grade 1 or ...

A Type B meeting between the FDA and Plus Therapeutics offered clarity and direction for the next steps in development of ...

Researchers at Moffitt Cancer Center have been awarded a $22.4 million grant from the U.S. Department of War to lead groundbreaking studies and clinical trials for leptomeningeal disease, a ...

Share on Facebook. Opens in a new tab or window Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window CHICAGO -- An ...

Researchers at Moffitt Cancer Center have reported encouraging results from a phase 1B clinical trial showing that the immunotherapy drug avelumab, when combined with whole brain radiotherapy, may ...

The following represents disclosure information provided by authors of this manuscript. All relationships are considered compensated. Relationships are self-held unless noted. I = Immediate Family ...